Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C155402-100 100 µl (1 mg/ml) $450 
DDX23 / PRP28 Antibody - Confocal immunofluorescence analysis (Olympus FV10i) of paraformaldehyde-fixed HeLa, using DDX23 antibody (Green) at 1:500 dilution. Alpha-tubulin filaments were labeled with alpha-tubulin antibody (Red) at 1:2000.
DDX23 / PRP28 Antibody - Sample (30 ug of whole cell lysate) A: NIH-3T3 B: JC 7.5% SDS PAGE DDX23 antibody diluted at 1:1000
DDX23 / PRP28 Antibody - Sample (30 ug of whole cell lysate) A: HeLa 7.5% SDS PAGE DDX23 antibody diluted at 1:1000
DDX23 / PRP28 Antibody - Confocal immunofluorescence analysis (Olympus FV10i) of paraformaldehyde-fixed HeLa, using DDX23 antibody (Green) at 1:500 dilution. Alpha-tubulin filaments were labeled with alpha-tubulin antibody (Red) at 1:2000.
DDX23 / PRP28 Antibody - Sample (30 ug of whole cell lysate) A: NIH-3T3 B: JC 7.5% SDS PAGE DDX23 antibody diluted at 1:1000
DDX23 / PRP28 Antibody - Sample (30 ug of whole cell lysate) A: HeLa 7.5% SDS PAGE DDX23 antibody diluted at 1:1000
1 of 3
2 of 3
3 of 3

Polyclonal Rabbit anti‑Human DDX23 / PRP28 Antibody (IF, WB) LS‑C155402

Polyclonal Rabbit anti‑Human DDX23 / PRP28 Antibody (IF, WB) LS‑C155402

Antibody:
DDX23 / PRP28 Rabbit anti-Human Polyclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Bovine
Format:
Unconjugated, Unmodified
Price
Catalog Number
$450
LS-C155402-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
DDX23 / PRP28 Rabbit anti-Human Polyclonal Antibody
Application:
ICC, IF, WB
Reactivity:
Human, Bovine
Format:
Unconjugated, Unmodified

Specifications

Description
PRP28 antibody LS-C155402 is an unconjugated rabbit polyclonal antibody to PRP28 (DDX23) from human. It is reactive with human and bovine. Validated for ICC, IF and WB.
Target
Human DDX23 / PRP28
Synonyms
DDX23 | DEAD box protein 23 | PRP28 homolog, yeast | PRPF28 | Prp28 | U5-100KD | U5 snRNP 100 kD protein | PRP28 homolog | PRP28p homolog | U5-100K
Host
Rabbit
Reactivity
Human, Bovine (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
Recombinant protein encompassing a sequence within the center region of human DDX23. The exact sequence is proprietary.
Specificity
Human, mouse DDX23
Applications
  • ICC (1:100 - 1:1000)
  • Immunofluorescence (1:100 - 1:1000)
  • Western blot (1:500 - 1:3000)
Usage
Suggested starting dilutions are as follows: Western blot: 1:500-1:3000, ICC/IF: 1:100-1:1000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.
Presentation
1X PBS, pH 7, 0.01% Thimerosal, 20% Glycerol, 1% BSA
Storage
Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About DDX23 / PRP28
Q9BUQ8 NM_004818 NP_004809.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/25/2024